Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
594 | 3 | OUABAIN//NA K ATPASE//DIGOXIN | 14893 |
1457 | 2 | DIGOXIN//ASCLEPIADACEAE//OUABAIN | 8054 |
13949 | 1 | BUFALIN//BUFADIENOLIDES//CINOBUFAGIN | 833 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | BUFALIN | authKW | 2609170 | 12% | 69% | 100 |
2 | BUFADIENOLIDES | authKW | 2069560 | 12% | 56% | 97 |
3 | CINOBUFAGIN | authKW | 1345195 | 5% | 89% | 40 |
4 | CHAN SU | authKW | 1263275 | 4% | 90% | 37 |
5 | TOAD VENOM | authKW | 898832 | 3% | 85% | 28 |
6 | RESIBUFOGENIN | authKW | 605326 | 3% | 67% | 24 |
7 | CINOBUFACINI | authKW | 378339 | 1% | 100% | 10 |
8 | ARENOBUFAGIN | authKW | 306453 | 1% | 90% | 9 |
9 | OLEANDRIN | authKW | 276710 | 2% | 46% | 16 |
10 | CINOBUFACINI INJECTION | authKW | 264837 | 1% | 100% | 7 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2657 | 34% | 0% | 282 |
2 | Integrative & Complementary Medicine | 2146 | 6% | 0% | 53 |
3 | Chemistry, Medicinal | 1998 | 15% | 0% | 125 |
4 | Oncology | 1419 | 23% | 0% | 190 |
5 | Toxicology | 323 | 7% | 0% | 55 |
6 | Plant Sciences | 157 | 8% | 0% | 63 |
7 | Cell Biology | 125 | 8% | 0% | 69 |
8 | Chemistry, Analytical | 101 | 6% | 0% | 52 |
9 | Biochemistry & Molecular Biology | 80 | 13% | 0% | 106 |
10 | Biochemical Research Methods | 79 | 4% | 0% | 35 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOL CELULAR MUTAGENICIDADE | 75668 | 0% | 100% | 2 |
2 | MED PHARMACOL MIZUHO KU | 75664 | 0% | 50% | 4 |
3 | BIOL CELULAR INOVACAO BIOTECNOL | 50444 | 0% | 67% | 2 |
4 | PHARMACOKINET DRUG TRANSPORT | 48640 | 0% | 43% | 3 |
5 | ADEPARTMENT PHARMACEUT | 37834 | 0% | 100% | 1 |
6 | ANHUI ENGN TECHNOL BIOCHEM | 37834 | 0% | 100% | 1 |
7 | BASIC MEDCHEM BIOL CELL DIFFEREN | 37834 | 0% | 100% | 1 |
8 | BIOCHEM CALS LTD | 37834 | 0% | 100% | 1 |
9 | CAMPUS SENATOR HELVIDO NUNES BARROS | 37834 | 0% | 100% | 1 |
10 | CANC TRADIT CHINESE MED TCM | 37834 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH | 4977 | 2% | 1% | 17 |
2 | AMERICAN JOURNAL OF CHINESE MEDICINE | 2140 | 1% | 1% | 11 |
3 | TOXICON | 1405 | 2% | 0% | 16 |
4 | MOLECULAR INTERVENTIONS | 1268 | 0% | 2% | 2 |
5 | FOLIA PHARMACOLOGICA JAPONICA | 1229 | 1% | 1% | 6 |
6 | BIOSCIENCE TRENDS | 1179 | 0% | 1% | 4 |
7 | JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES | 1008 | 0% | 1% | 4 |
8 | ONCOTARGET | 991 | 3% | 0% | 21 |
9 | JOURNAL OF NATURAL PRODUCTS | 977 | 2% | 0% | 18 |
10 | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 913 | 1% | 0% | 12 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BUFALIN | 2609170 | 12% | 69% | 100 | Search BUFALIN | Search BUFALIN |
2 | BUFADIENOLIDES | 2069560 | 12% | 56% | 97 | Search BUFADIENOLIDES | Search BUFADIENOLIDES |
3 | CINOBUFAGIN | 1345195 | 5% | 89% | 40 | Search CINOBUFAGIN | Search CINOBUFAGIN |
4 | CHAN SU | 1263275 | 4% | 90% | 37 | Search CHAN+SU | Search CHAN+SU |
5 | TOAD VENOM | 898832 | 3% | 85% | 28 | Search TOAD+VENOM | Search TOAD+VENOM |
6 | RESIBUFOGENIN | 605326 | 3% | 67% | 24 | Search RESIBUFOGENIN | Search RESIBUFOGENIN |
7 | CINOBUFACINI | 378339 | 1% | 100% | 10 | Search CINOBUFACINI | Search CINOBUFACINI |
8 | ARENOBUFAGIN | 306453 | 1% | 90% | 9 | Search ARENOBUFAGIN | Search ARENOBUFAGIN |
9 | OLEANDRIN | 276710 | 2% | 46% | 16 | Search OLEANDRIN | Search OLEANDRIN |
10 | CINOBUFACINI INJECTION | 264837 | 1% | 100% | 7 | Search CINOBUFACINI+INJECTION | Search CINOBUFACINI+INJECTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |